Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof

HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof

US Patent 7871625 · Granted Jan 18, 2011

Estimated economic value: $13,979,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HCV NS4a/modified NS3 polypeptides and uses thereof2020
HCV NS4a/modified NS3 polypeptides and uses thereof2020
HCV NS4a/modified NS3 polypeptides and uses thereof2020
Norovirus derived immunogenic compositions and methods2019
Norovirus derived immunogenic compositions and methods2019
HCV NS4A/modified NS3 polypeptides and uses thereof2019
HCV NS4A/modified NS3 polypeptides and uses thereof2019
HCV NS4A/modified NS3 polypeptides and uses thereof2019
Norovirus derived immunogenic compositions and methods2018
Norovirus derived immunogenic compositions and methods2018
Method for generating a parvovirus B19 virus-like particle2017
Method for generating a parvovirus B19 virus-like particle2017